CVS Health Corp vs Invesco Ltd. — how do they compare? CVS Health Corp trades at $93.62 (market cap $119.58B), while Invesco Ltd. trades at $31.16 (market cap $13.85B). The key difference: CVS Health Corp is far larger — about 8.6× Invesco Ltd.'s market cap, and CVS Health Corp pays the higher dividend (2.84%). Which is the better fit depends on your goals.
| CVS | IVZ | |
|---|---|---|
Market Cap | $119.58B | $13.85B |
Sector | Health | Financials |
52-Week High | $110.60 | $32.01 |
52-Week Low | $65.51 | $20.67 |
Enterprise Value | $181.93B | $24.01B |
Dividend Yield | 2.84% | 2.74% |
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →